Antimicrobial Resistance (AMR) in post COVID era – ‘Second Pandemic’ Slowly Moving Across the World

{"title":"Antimicrobial Resistance (AMR) in post COVID era – ‘Second Pandemic’ Slowly Moving Across the World","authors":"","doi":"10.47883/jszmc.v13i3.250","DOIUrl":null,"url":null,"abstract":"Antimicrobials are the drugs used to prevent and treat infections caused by bacteria, viruses, fungi and parasites in humans, animals and plants. Their use is increasing globally, across the species with desired beneficial effects when used judiciously. On the other hand, their overuse for prolonged period of time in unjustified doses, duration and indication is leading to drug resistance. Consequently, these agents are becoming ineffective rendering the management of infections increasingly difficult or impossible. In a way, drug resistance is largely a man-made problem and it can be tackled with good prescribing practices. Growing trends in the emergence of AMR is considered a major threat to global health and economy. World Health Organisation (WHO) considered it one of the top 10 global health threats. \n\nO'Neill J. et al published an excellent review on antimicrobial resistance in 2016. In this report, they studied the global trends, track the possible result of drug-resistant infections on health and economy globally if issue unaddressed and gave recommendations to tackle this menace.1 Even at the time of collection of data (2014-16), AMR was directly responsible for death of 700,000 deaths. It was estimated that if the trends went on un-addressed, world may see loss of 10 million lives by 2050, overtaking diabetes, heart disease and cancer as the leading cause of death in human and an approximate cost reaching 100 trillion USD. No country or region is immune but the low and middle-income countries are likely to suffer most.\n\n \n\nAlthough some experts and researcher had doubts about these estimates, 2,3 WHO and most of other authorities agree that the spread of AMR is a real, seriously growing global threat to be addressed by a well-coordinated global action plan.\n\nA recently published systematic analysis confirmed rising trends. Data from 204 countries and territories showed an estimated 1.27 million deaths caused directly by AMR worldwide, and 4.95 million deaths were associated with AMR, in 2019, higher than the mortality of HIV/AIDS and malaria which have been estimated to be 860,000 and 640,000 deaths, respectively, in same year.4\n\n \n\nAfter the start of COVID -19, in 2020 hospitals have to cater a different patient population. Higher number of seriously ill, aged patients with comorbidities, who needed intensive care for a prolonged period. Without a clear guideline to deal with the newly emerged infectious outbreak, multiple therapeutic agents were used. These agents included many antibiotics, antiviral and sometimes antifungal agents used empirically. Many new and old drugs were also used on experimental basis. Additionally, all the seriously ill patients received corticosteroids as recommended in guidelines and many of the patients required invasive devices, equipment or catheters etc. for prolong time. All these are risk factors for development of drug resistance. To make the situation worse, due to increased burden of seriously ill patients, many temporary/makeshift ICUs have to be started with inadequately trained staff and compromised preventive measures. Lack of proper personal protective equipment for the health care workers and patients and their carers promoted the spread of infection in hospitals and communities. \n\nEvidence has proved that the single most important risk factor for the development of drug resistant bugs is prolonged use of broad-spectrum antibiotics. Although Viral aetiology of Covid -19 was established right from start of pandemic, but still majority of patients received antibiotics. Langford and colleagues5 performed a systematic meta-analysis of studies published in English language on this subject from 2019 to April 16, 2020. Out of 1308 studies, 24 qualified for inclusion into this meta-analysis. A total of 3338 patients in the 24 studies were evaluated for acute bacterial infection. Overall, only 6.9% (95%CI 4.3-9.5%) had bacterial infection (either at time of presentation or acquired as secondary infection during course of disease) while 71.9%, (95%CI 56.1 to 87.7%) received antibiotics. This unjustified excessive use of antibiotics in Covid patients with a threat to development of drug resistance has been widely reported in other publications as well.6,7,8\n\nUnfortunately, social media also played a negative part. Many drugs including some antibiotics have been promoted as magical cures without any evidence. Many world leaders and even some health professionals also become a tool in spreading incorrect information which led to self-medication. Relevant authorities failed to counter this false campaign resulting in over the counter sale of such agents without prescription. Azithromycin is one of the many such agents which gained undue reputation as curative and preventive therapy. Demand was so high that many pharmaceuticals (more than 20 companies in Pakistan) started manufacturing and marketing azithromycin. Macrolides are already known to have high level microbial resistance,9,10 what havoc this excessive usage will play is within everyone’s imagination. Remember, this unjustified use is not limited to one antibiotic, all new and old, narrow and broad-spectrum antibiotics have the same fate. Exact scale of AMR in post Covid era is yet to be seen. It must be noted that this unjustified use is not limited to antibiotics only, same hold true for other antimicrobials like antifungal, antiviral and others. Authorities consider AMR, a ‘Second Pandemic’ which may speed up the emergence of drug resistance. If corrective measures are not taken, the estimated yearly mortality of 10 million1 due to AMR in 2050 may be seen much earlier. No stone should be left unturned to halt this deadly second pandemic. Authorities must focus on health care workers for judicious use of antimicrobial agents but must not ignore the health education of general public and media. It is important to convey all to learn and comply the principles of healthy life and be a safe patient. Avoiding the development of disease and prevention of its spread to others is responsibility of every member of society. Covid -19 pandemic has proved beyond doubt that only coordinated efforts by all can help tackle such disasters. Let’s not be complacent, and continue in same manner we did during pandemic to avoid AMR catastrophe.","PeriodicalId":171893,"journal":{"name":"Journal of Sheikh Zayed Medical College","volume":"39 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Sheikh Zayed Medical College","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47883/jszmc.v13i3.250","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Antimicrobials are the drugs used to prevent and treat infections caused by bacteria, viruses, fungi and parasites in humans, animals and plants. Their use is increasing globally, across the species with desired beneficial effects when used judiciously. On the other hand, their overuse for prolonged period of time in unjustified doses, duration and indication is leading to drug resistance. Consequently, these agents are becoming ineffective rendering the management of infections increasingly difficult or impossible. In a way, drug resistance is largely a man-made problem and it can be tackled with good prescribing practices. Growing trends in the emergence of AMR is considered a major threat to global health and economy. World Health Organisation (WHO) considered it one of the top 10 global health threats. O'Neill J. et al published an excellent review on antimicrobial resistance in 2016. In this report, they studied the global trends, track the possible result of drug-resistant infections on health and economy globally if issue unaddressed and gave recommendations to tackle this menace.1 Even at the time of collection of data (2014-16), AMR was directly responsible for death of 700,000 deaths. It was estimated that if the trends went on un-addressed, world may see loss of 10 million lives by 2050, overtaking diabetes, heart disease and cancer as the leading cause of death in human and an approximate cost reaching 100 trillion USD. No country or region is immune but the low and middle-income countries are likely to suffer most. Although some experts and researcher had doubts about these estimates, 2,3 WHO and most of other authorities agree that the spread of AMR is a real, seriously growing global threat to be addressed by a well-coordinated global action plan. A recently published systematic analysis confirmed rising trends. Data from 204 countries and territories showed an estimated 1.27 million deaths caused directly by AMR worldwide, and 4.95 million deaths were associated with AMR, in 2019, higher than the mortality of HIV/AIDS and malaria which have been estimated to be 860,000 and 640,000 deaths, respectively, in same year.4 After the start of COVID -19, in 2020 hospitals have to cater a different patient population. Higher number of seriously ill, aged patients with comorbidities, who needed intensive care for a prolonged period. Without a clear guideline to deal with the newly emerged infectious outbreak, multiple therapeutic agents were used. These agents included many antibiotics, antiviral and sometimes antifungal agents used empirically. Many new and old drugs were also used on experimental basis. Additionally, all the seriously ill patients received corticosteroids as recommended in guidelines and many of the patients required invasive devices, equipment or catheters etc. for prolong time. All these are risk factors for development of drug resistance. To make the situation worse, due to increased burden of seriously ill patients, many temporary/makeshift ICUs have to be started with inadequately trained staff and compromised preventive measures. Lack of proper personal protective equipment for the health care workers and patients and their carers promoted the spread of infection in hospitals and communities. Evidence has proved that the single most important risk factor for the development of drug resistant bugs is prolonged use of broad-spectrum antibiotics. Although Viral aetiology of Covid -19 was established right from start of pandemic, but still majority of patients received antibiotics. Langford and colleagues5 performed a systematic meta-analysis of studies published in English language on this subject from 2019 to April 16, 2020. Out of 1308 studies, 24 qualified for inclusion into this meta-analysis. A total of 3338 patients in the 24 studies were evaluated for acute bacterial infection. Overall, only 6.9% (95%CI 4.3-9.5%) had bacterial infection (either at time of presentation or acquired as secondary infection during course of disease) while 71.9%, (95%CI 56.1 to 87.7%) received antibiotics. This unjustified excessive use of antibiotics in Covid patients with a threat to development of drug resistance has been widely reported in other publications as well.6,7,8 Unfortunately, social media also played a negative part. Many drugs including some antibiotics have been promoted as magical cures without any evidence. Many world leaders and even some health professionals also become a tool in spreading incorrect information which led to self-medication. Relevant authorities failed to counter this false campaign resulting in over the counter sale of such agents without prescription. Azithromycin is one of the many such agents which gained undue reputation as curative and preventive therapy. Demand was so high that many pharmaceuticals (more than 20 companies in Pakistan) started manufacturing and marketing azithromycin. Macrolides are already known to have high level microbial resistance,9,10 what havoc this excessive usage will play is within everyone’s imagination. Remember, this unjustified use is not limited to one antibiotic, all new and old, narrow and broad-spectrum antibiotics have the same fate. Exact scale of AMR in post Covid era is yet to be seen. It must be noted that this unjustified use is not limited to antibiotics only, same hold true for other antimicrobials like antifungal, antiviral and others. Authorities consider AMR, a ‘Second Pandemic’ which may speed up the emergence of drug resistance. If corrective measures are not taken, the estimated yearly mortality of 10 million1 due to AMR in 2050 may be seen much earlier. No stone should be left unturned to halt this deadly second pandemic. Authorities must focus on health care workers for judicious use of antimicrobial agents but must not ignore the health education of general public and media. It is important to convey all to learn and comply the principles of healthy life and be a safe patient. Avoiding the development of disease and prevention of its spread to others is responsibility of every member of society. Covid -19 pandemic has proved beyond doubt that only coordinated efforts by all can help tackle such disasters. Let’s not be complacent, and continue in same manner we did during pandemic to avoid AMR catastrophe.
后COVID时代的抗菌素耐药性——“第二次大流行”在全球缓慢蔓延
抗菌剂是用于预防和治疗人类、动物和植物中由细菌、病毒、真菌和寄生虫引起的感染的药物。它们的使用在全球范围内正在增加,在整个物种中,如果明智地使用,会产生预期的有益效果。另一方面,它们在不合理的剂量、持续时间和适应症下长时间过度使用导致耐药性。因此,这些药物变得无效,使感染管理变得越来越困难或不可能。在某种程度上,耐药性在很大程度上是一个人为的问题,它可以通过良好的处方实践来解决。抗菌素耐药性出现的日益增长的趋势被认为是对全球健康和经济的主要威胁。世界卫生组织(WHO)认为它是全球十大健康威胁之一。O’neill J.等人在2016年发表了一篇关于抗菌素耐药性的优秀综述。在本报告中,他们研究了全球趋势,跟踪了如果问题得不到解决,耐药感染对全球健康和经济可能造成的后果,并提出了应对这一威胁的建议即使在收集数据时(2014- 2016年),抗微生物药物耐药性也直接导致了70万人死亡。据估计,如果这一趋势得不到解决,到2050年,世界可能会失去1 000万人的生命,超过糖尿病、心脏病和癌症,成为人类死亡的主要原因,造成的损失约达100万亿美元。没有一个国家或区域能够幸免,但低收入和中等收入国家可能受害最深。尽管一些专家和研究人员对这些估计持怀疑态度,但世卫组织和大多数其他权威机构一致认为,抗生素耐药性的传播是一个真实的、日益严重的全球威胁,需要通过协调良好的全球行动计划加以解决。最近发表的一项系统分析证实了这种上升趋势。来自204个国家和地区的数据显示,2019年,全球估计有127万人直接死于抗微生物药物耐药性,495万人的死亡与抗微生物药物耐药性有关,高于同年艾滋病毒/艾滋病和疟疾的死亡率,估计分别为86万人和64万人在2019冠状病毒病开始后,到2020年,医院必须满足不同的患者群体。患有合并症的老年重症患者数量增加,需要长期重症监护。由于没有明确的指导方针来应对新出现的传染病暴发,因此使用了多种治疗药物。这些药物包括许多抗生素、抗病毒药物,有时还包括经验使用的抗真菌药物。许多新药和旧药也在实验基础上使用。此外,所有重症患者均按照指南建议使用皮质类固醇,许多患者需要延长侵入性装置、设备或导管等。所有这些都是产生耐药性的危险因素。更糟糕的是,由于重症患者的负担增加,许多临时/临时icu不得不在工作人员训练不足和预防措施打折扣的情况下开始。医护人员和病人及其护理人员缺乏适当的个人防护装备,促进了感染在医院和社区的传播。有证据证明,产生耐药细菌的一个最重要的危险因素是长期使用广谱抗生素。虽然从大流行开始就确定了Covid -19的病毒病原学,但大多数患者仍接受了抗生素治疗。兰福德及其同事对2019年至2020年4月16日期间以英语发表的有关这一主题的研究进行了系统的荟萃分析。在1308项研究中,有24项符合纳入本荟萃分析的条件。在24项研究中,共有3338名患者被评估急性细菌感染。总体而言,只有6.9% (95%CI 4.3-9.5%)的患者有细菌感染(在发病时或在疾病过程中继发感染),而71.9% (95%CI 56.1 - 87.7%)的患者接受了抗生素治疗。其他出版物也广泛报道了在Covid - 19患者中不合理地过度使用抗生素可能产生耐药性的情况。不幸的是,社交媒体也起到了消极的作用。包括一些抗生素在内的许多药物在没有任何证据的情况下被宣传为神奇的治疗方法。许多世界领导人,甚至一些卫生专业人员也成为传播错误信息的工具,导致自我用药。有关部门未能打击这种虚假宣传,导致这些药物在没有处方的情况下在柜台销售。阿奇霉素是许多此类药物之一,作为治疗和预防治疗获得了不应有的声誉。需求如此之高,以至于许多制药公司(巴基斯坦有20多家公司)开始生产和销售阿奇霉素。 众所周知,大环内酯类药物具有高度的微生物耐药性,9,10这种过度使用会造成多大的破坏是每个人都能想象到的。请记住,这种不合理的使用并不局限于一种抗生素,所有新的和旧的,窄谱和广谱抗生素都有同样的命运。后冠状病毒时代抗菌素耐药性的确切规模还有待观察。必须指出的是,这种不合理的使用不仅限于抗生素,也适用于其他抗菌剂,如抗真菌药、抗病毒药物和其他抗菌剂。有关当局认为抗生素耐药性是“第二次大流行”,可能会加速耐药性的出现。如果不采取纠正措施,2050年估计每年因抗菌素耐药性死亡1 000万人的情况可能会更早出现。应该不遗余力地制止这一致命的第二次大流行。当局必须把重点放在卫生保健工作者明智地使用抗微生物药物上,但绝不能忽视公众和媒体的健康教育。重要的是要传达所有的学习和遵守健康生活原则,做一个安全的病人。避免疾病的发展和防止其传播给他人是每个社会成员的责任。新冠肺炎疫情充分证明,只有各方同心协力,才能战胜疫情。让我们不要自满,继续像我们在大流行期间所做的那样,以避免抗菌素耐药性灾难。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信